A lthough the role for nitric oxide (NO) as a cytotoxic effector molecule of the immune surveillance system is clearly established, 1 recent evidence demonstrates a cytoprotective function for NO at lower nontoxic concentrations. Cellular protection by NO may occur independently of its vasodilatory effect and is therefore not necessarily a consequence of increased blood or nutrient flow to tissues under cytotoxic stress. Thus, NO was reported to reduce cellular damage inflicted by oxidant stress in endothelial cells and fibroblasts. 2, 3 Previous investigations from our laboratory demonstrated that NO induces long-term protection against endothelial injury caused by tumor necrosis factor (TNF)-␣. 4, 5 The basic mechanisms of NO-dependent cytoprotection are diverse and include direct neutralization of the superoxide radical 2, 6 or inhibition of proapoptotic enzymes, such as caspase-3-like proteins, through S-nitrosylation. 7, 8 These actions are cGMP independent; ie, they do not require increased activity of soluble guanylyl cyclase, the target enzyme of NO in many biological systems. 7 By contrast, endothelial protection afforded by NO against the deleterious effects of proinflammatory cytokines has clearly been shown to be cGMP dependent. 4, 9 Similarly, cGMP has emerged as a crucial mediator of cytoprotection in the central nervous system and the immune system. 10 -15 In endothelial cells, cellular resistance to oxidant damage or TNF-␣ toxicity has a delayed onset when induced through the NO/cGMP pathway, and some studies have shown that it can be prevented by pretreatment with cycloheximide, indicating upregulation of protective proteins. 9, 16, 17 Growing evidence points to the central role of heme oxygenase-1 (HO-1, heat shock protein 32) as an inducible stress gene that confers cytoprotection through the generation of vasodilatory CO and antioxidant bilirubin. 18, 19 In addition to its general anti-inflammatory function, 20 HO-1 specifically prevents chronic rejection or arteriosclerosis of transplants, according to recent investigations, 21, 22 and enhances the resistance of pancreatic islet cells to cytokine-mediated injury. 23 Moreover, the first human case of HO-1 deficiency, which has been reported to be due to a genetic disorder, shows severe persistent endothelial damage and increased tissue vulnerability to oxidant injury besides growth retardation and anemia. 24 Although induction of HO-1 by NO has been reported in endothelial and vascular smooth muscle cells, the underlying signaling pathway, particularly with regard to a possible participation of cGMP, is unclear. [25] [26] [27] Moreover, whether among the considerable number of NO-sensitive protective genes, such as bcl-2, heat shock protein 70, ferritin, and others, 8, 16, 28, 29 HO-1 makes a significant contribution to NO-mediated cellular protection has not been addressed; ie, a causal link between the increased cellular defense after NO treatment and the induction of HO-1 protein synthesis is still missing. Our aim, therefore, was to explore the role of cGMP in NO-dependent HO-1 induction and to assess the protective function of HO-1 in endothelial cells by using an antisense technique and the clinically used donor of NO, molsidomine (specifically, its active metabolite 3-morpholinosydnonimine [SIN-1]).
Methods

Materials
Bovine pulmonary artery endothelial cells (ATCC CCL 209) were obtained from the American Type Culture Collection. FBS, DMEM, and penicillin-streptomycin were obtained from GIBCO. TNF-␣ was a gift of Knoll Deutschland GmbH (Ludwigshafen, Germany). SIN-1 was provided by Hoechst AG (Frankfurt, Germany). S-Nitroso-N-acetyl-D,Lpenicillamine (SNAP), phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl-3-oxide (PTIO), tin protoporphyrin-IX (SnPP), and 1H- [1, 2, 4] oxadiazole [4,3-a] quinoxalin-1-one (ODQ) were purchased from Alexis. The chemiluminescence Western blotting kit was from Boehringer-Mannheim. The phosphorothioated oligonucleotides derived from the rat HO-1 sequence were synthesized at the Beckman Center, Stanford University, and were composed of the HO-1 transcription initiation codon and 6 bp on either side (antisense 5Ј-GCGCTCCATCGCGGG-3Ј). 30 Negative controls were the sense oligonucleotide (5Ј-CCCGCGATGGAGCGC-3Ј), a complementary sequence to the antisense, and a random or scrambled oligonucleotide (5Ј-GGCCCTCTACGGGCG-3Ј), which contained all of the base pairs of the antisense codon in random order. 30 cGMP analogues, human atrial natriuretic peptide (ANP), and all other chemicals were bought from Sigma Chemical Co.
Cell Culture
Endothelial cells were maintained and subcultured in DMEM supplemented with 15% FBS, 100 U/mL penicillin, and 100 g/mL streptomycin. 31 The cells were grown in a humidified incubator at 37°C and 5% CO 2 .
Cell Viability Analysis
Endothelial cells were seeded at 2ϫ10 4 cells per well in 96-well microtiter plates in 100 L of media containing 15% FBS. After a 48-hour incubation at 37°C, the cells reached confluence, oligonucleotides were added, and the cells were then incubated for 8 hours. Cells were washed and further incubated for 6 hours in the presence of SIN-1 or 8-bromo-cGMP. PTIO or SnPP was added to the cells 10 minutes before SIN-1. Then, TNF-␣ was given to the cells without washing out the previously added agents. Incubation at 37°C was continued for 72 hours and was followed by a cytotoxicity assay. Cell viability was measured by staining with crystal violet as previously described. 5, 32, 33 This colorimetric test allows assessment of the remaining viable cells after the incubation procedure. After they were washed with PBS, cells were fixed with methanol for 10 minutes and then stained for 10 minutes with a 0.1% crystal violet solution. After 3 washes with tap water, the dye was eluted with 0.1 mol/L trisodium citrate in 50% ethanol for 10 minutes. Optical density at 630 nm was measured by use of a microtiter plate reader (Biotek EL 311s).
Western Blot Analysis
Endothelial cells were cultured in 150-mm dishes as described above. After a 24-hour incubation with control media, SIN-1, 8-bromo-cGMP, dibutyryl cGMP, or ANP, cells were washed and extracted as described previously. 31 PTIO or ODQ was added to the cells 30 minutes before SIN-1. Protein (150 g) was applied to SDS-PAGE. After electrophoresis, protein was transferred to a nitrocellulose membrane, and a polyclonal antibody to rat HO-1 (Stressgene) was used to identify HO-1 protein content. Antigen antibody complexes were visualized with the horseradish peroxidase chemiluminescence system according to the manufacturer's instructions (Boehringer-Mannheim). Quantification of HO-1 protein content was performed by computer-assisted videodensitometry (Eagle Eye II-system, Stratagene).
Determination of cGMP
Cells grown to confluence in 35-mm cultured dishes were washed twice with 2 mL of a balanced salt solution containing 130 mmol/L NaCl, 5.4 mmol/L KCl, 1.8 mmol/L CaCl 2 , 5.5 mmol/L glucose, and 20 mmol/L HEPES-NaOH, buffered to pH 7.3. Cells were exposed for 10 minutes at 37°C to PTIO or vehicle in the balanced solution containing 0.5 mmol/L isobutylmethylxanthine. SIN-1 or ANP was added, and the incubation was continued for another 10 minutes at 37°C. The final assay volume was 1 mL. Supernatants were aspirated, and after addition of ethanol and subsequent evaporation, cGMP levels were determined by an enzyme-linked immunoassay according to the manufacturer's protocol (EIA kit, Cayman).
Heme Oxygenase Activity
Confluent endothelial cells in 150-mm culture dishes were incubated for 8 hours in the presence of control media, SIN-1, or 8-bromocGMP. The method used for the determination of heme oxygenase activity follows the protocol published by Motterlini et al. 3 Briefly, after the incubation, cells were washed twice with PBS, gently scraped off the dish, and centrifuged (1000g for 10 minutes at 4°C). The cell pellet was suspended in MgCl 2 (2 mmol/L) and phosphate (100 mmol/L) buffer (pH 7.4), frozen at Ϫ70°C, thawed 3 times, and finally sonicated on ice before centrifugation at 18 000g for 10 minutes at 4°C. The supernatant (400 L) was added to an NADPH-generating system containing 0.8 mmol/L NADPH, 2 mmol/L glucose-6-phosphate, 0.2 U glucose-6-phosphate-1-dehydrogenase, and 2 mg protein of rat liver cytosol prepared from the 105 000g supernatant fraction as a source of biliverdin reductase, potassium phosphate buffer (100 mmol/L, pH 7.4), and hemin (10 mol/L) in a final volume of 200 L. The reaction was conducted for 1 hour at 37°C in the dark and terminated by the addition of 1 mL chloroform. The extracted bilirubin was calculated by the difference in absorption between 464 and 530 nm with use of a quartz cuvette (extinction coefficient, 40 mmol ⅐ L Ϫ1 ⅐ cm Ϫ1 for bilirubin). Heme oxygenase activity was expressed as picomoles of bilirubin formed per milligram of endothelial cell protein per hour.
Results
HO-1 Protein Expression
In bovine pulmonary artery endothelial cells, SIN-1 (1 to 100 mol/L) and SNAP (1 to 100 mol/L/L) induced the synthesis of HO-1 protein in a concentration-dependent fashion up to 3-fold over basal levels (Figures 1 and 2 ). HO-1 induction by SIN-1 was inhibited in the presence of the NO scavenger PTIO and the inhibitor of soluble guanylyl cyclase ODQ but remained unchanged in the presence of the superoxide scavenger superoxide dismutase (SOD, Figure 3 ). The membranepermeable cGMP analogues 8-bromo-cGMP (1 to 100 mol/L) and dibutyryl cGMP (1 to 100 mol/L) as well as the activator of particulate guanylyl cyclase ANP (1 to 100 nmol/L) produced increases in HO-1 protein in a concentration-dependent manner and similar to increases produced by SIN-1 (Figures 4 and 5 ). Cells were incubated for 24 hours with control media, SIN-1, cGMP Levels SIN-1 (1 to 100 mol/L) and ANP (1 to 100 nmol/L) stimulated endothelial cGMP accumulation at concentrations that were also effective in HO-1 induction ( Figure 6 ). SIN-1-induced cGMP stimulation was inhibited by PTIO ( Figure 6A ). Cells were exposed for 10 minutes to PTIO or vehicle in the balanced solution containing 0.5 mmol/L isobutylmethylxanthine. SIN-1 or ANP was added, and the incubation was continued for another 10 minutes. PTIO alone was without influence on basal cGMP levels under these conditions (not shown).
Heme Oxygenase Activity
Cells were exposed to SIN-1 or 8-bromo-cGMP for 8 hours. Heme oxygenase activity was assessed in the cell lysate by measuring formation of the heme oxygenase metabolite bilirubin. SIN-1 (0.01 to 1 mmol/L) produced a concentrationdependent increase in heme oxygenase activity up to 5-fold over basal levels ( Figure 7A ). Similar results were obtained when 
Endothelial Cell Viability
Hemin, the established activator of HO-1 expression increased the number of surviving cells in TNF-␣-treated cultures in a concentration-dependent fashion (Figure 8 ). Endothelial protection by NO donors was abrogated in the presence of the heme oxygenase inhibitor SnPP (Figure 9 ). Pretreatment of cells with a phosphorothioate-linked HO-1 antisense oligonucleotide prevented protection by SIN-1 ( Figure 10 ) or 8-bromo-cGMP ( Figure 11 ) against TNF-␣ cytotoxicity, whereas sense and scrambled HO-1 were without effect under these conditions. In control experiments, antisense HO-1 showed a similar specificity in blocking HO-1 protein induction by SIN-1 (see insert Figure 10 ). Cells were incubated with HO-1 oligonucleotides for 8 hours and were then washed. PTIO or SnPP was added to the cells 10 minutes before SIN-1 and was not washed out ( Figure 6 ). Cells were further incubated in the presence of 8-bromocGMP or SIN-1 for 6 hours. TNF-␣ was given to the cells without washing out 8-bromo-cGMP or SIN-1. Incubation was continued for 72 hours and was followed by a viability assay. SIN-1, 8-bromo-cGMP, oligonucleotides, or PTIO alone had no significant effect on cell viability under these conditions (not shown).
Discussion
The present study shows, for the first time, that cGMP is a crucial mediator in the endothelial regulation of HO-1 expression and that endothelial protection afforded by the NO/cGMP system is causally related to the induction of HO-1.
In the present study, TNF-␣-induced endothelial toxicity serves as a model to study long-term protection from oxidant stress. TNF-␣ is a proinflammatory cytokine with a direct toxic effect on the endothelium, resulting in endothelial lesions that favor thrombus formation and atherogenesis. This direct necrotic effect of TNF-␣ is caused, to a substantial degree, by the formation of reactive oxygen species. 34, 35 Moreover, the crucial role of oxidant stress in TNF-␣-mediated cellular injury was previously established by using the same endothelial cell type as used in the present study. 36 SIN-1, the active metabolite of the antianginal drug molsidomine, was used as an NO-releasing and HO-1-inducing agent in the present study. Although under certain conditions (eg, in the absence of biological material or in pure aqueous solutions) SIN-1 is known to generate superoxide or peroxynitrite rather than NO, 37 data from a number of sources, including ours, have clearly shown that SIN-1 in intact cells (ie, in the presence of electron acceptors other than oxygen) functions as a true donor of NO. 6, 16, 38 Moreover, and in agreement with this, we report in the present study that HO-1 induction by SIN-1 is inhibited by the NO scavenger PTIO 39 but not by SOD. That NO plays a key role as an active SIN-1 metabolite is further evident from our observation that SIN-1 produced a significant cGMP increase, which was also susceptible to inhibition by PTIO.
The regulatory role of cGMP can be derived from the stimulatory effect of membrane-permeable cGMP analogues on HO-1 protein synthesis and is further highlighted by our finding that ODQ, the inhibitor of soluble guanylyl cyclase, 40 attenuates HO-1 induction by the NO donor SIN-1. Whereas Immenschuh et al 41 clearly showed cGMP to activate HO-1 transcription in hepatocytes, other authors were not able to demonstrate a signaling function of cGMP in endothelial HO-1 regulation. 3 In that latter study, however, the only experimental approach to explore the involvement of cGMP was assessing a possible stimulatory effect of 8-bromo-cGMP on HO-1 catalytic activity. 3 It is known that membrane permeability of, and cellular responsiveness to, cyclic nucleotide analogues may vary despite the existence of specific cGMP binding sites, 42 which could be why cGMP sensitivity of HO-1 regulation was not detected in previous reports. 3, 43 The present study, in addition to showing HO-1 induction by exogenous cGMP and its inhibition by ODQ, provides a third line of evidence for the signaling role of cGMP in endothelial HO-1 expression by including experiments with ANP, a direct activator of particulate guanylyl cyclase. ANP at nanomolar concentrations that were previously shown to result in increased particulate guanylyl cyclase activity and cellular cGMP in kidney cells 44, 45 led to a robust elevation of cGMP accumulation and HO-1 protein expression in endothelial cells. This is the first time that ANP has been linked to HO-1 expression. Beyond a generally improved defense against oxidant injury, induction of an anti-inflammatory protein by activators of particulate guanylyl cyclase may have specific clinical implications because (1) ANP and related compounds reduce drug-induced nephrotoxicity in transplant recipients, 46, 47 and (2) increased HO-1 expression is considered to protect against the chronic rejection of transplants. 19 -21 In the present study, however, HO-1 induction by hours. TNF-␣ was given to the cells without washing out hemin. Incubation was continued for 72 hours and was followed by a viability assay, which was carried out as described in Methods. *PϽ0.05 for treatment vs CON by one-way ANOVA and Bonferroni multiple comparison test. All data shown are meanϮSEM of 6 independent observations in separate cell culture wells. . Cells were incubated with CON, SIN-1, or SNAP for 6 hours. SnPP was added to the cells 10 minutes before the NO donors. TNF-␣ was given to the cells without washing out the NO donors or SnPP. Incubation was continued for 72 hours and was followed by a viability assay, which was carried out as described in Methods. *PϽ0.05 for treatment vs CON by one-way ANOVA and Bonferroni multiple comparison test. All data shown are meanϮSEM of 6 independent observations in separate cell culture wells.
ANP is mainly interpreted as a crucial observation that substantiates cGMP sensitivity of endothelial HO-1 expression. That HO-1 may contain cyclic nucleotide-responsive elements is also suggested by recent investigations of HO-1 regulation in smooth muscle and liver tissue. 27, 48 To find out whether HO-1 induction and cytoprotection by NO/cGMP are causally related, the present study uses an antisense oligonucleotide to HO-1. Antisense HO-1 attenuated endothelial protection against TNF-␣ by SIN-1 and 8-bromo-cGMP, whereas after treatment with sense or scrambled HO-1, the surviving cell fractions remained unaltered. In additional control experiments, the same specificity of antisense HO-1 was found for inhibition of SIN-1-induced HO-1 protein expression. SIN-1 and 8-bromo-cGMP stimulated heme oxygenase activity, ie, bilirubin formation. Moreover, endothelial protection by NO donors was abrogated in the presence of the heme oxygenase inhibitor SnPP. 18, 20 Thus, increased expression of HO-1 by SIN-1 and its causal relation to ensuing cytoprotection is also reflected at the level of enzymatic activity. These results, in our view, conclusively demonstrate the decisive role that HO-1 plays in mediating endothelial protection by the NO/cGMP system. The pathway, through which cGMP induces HO-1 and as a consequence endothelial resistance to cytotoxic stress, could be a direct one, ie, via cGMP-sensitive transcription factors, such as activator protein-1. 49 Alternatively, cGMP may act through secondary increases in cAMP, which we reported previously to occur in endothelial cells in response to NO donors and which are possibly due to cGMP-elicited inhibition of cAMP breakdown. 5 Because activator protein-1 and cAMP-responsive elements have been identified in the promoter region of HO-1, 27,41,48,50 HO-1 induction by NO/cGMP may be regulated through different mechanisms, depending on species and tissue.
We have shown, for the first time, that cGMP is a regulator of HO-1 expression in endothelial cells. Moreover, according to our data, induction of the defense protein HO-1 is clearly responsible for the endothelial protection afforded by the NO/cGMP system against the cytotoxic effects of TNF-␣. Thus, HO-1 is an important cellular target of NO donors, with clinical implications for the therapy or prevention of atherosclerosis and inflammatory diseases. 11 . Effect of AS, S, and Scr HO-1 (all oligonucleotides at 20 ng/mL) on protection induced by 8-Br-cGMP against TNF-␣ toxicity in endothelial cells. Cells were incubated with HO-1 oligonucleotides for 8 hours and washed. Then, cells were further incubated in the presence of 8-Br-cGMP for 6 hours. TNF-␣ was given to the cells without washing out 8-Br-cGMP. Incubation was continued for 72 hours and was followed by a viability assay, which was carried out as described in Methods. *PϽ0.05 for treatment vs CON by one-way ANOVA and Bonferroni multiple comparison test. 
